A panel of independent experts to the C.D.C. says it needs more time to assess data and risks during the Johnson & Johnson vaccine pause.
The emergency meeting on Wednesday came after federal health authorities said they were studying rare blood clots in a small number of vaccine recipients and injections of the vaccine were halted across the country.
